The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

被引:2
|
作者
Lu, Yan [1 ]
Lin, Bo [1 ]
Li, Mengsen [1 ,2 ,3 ]
机构
[1] Hainan Med Coll, Hainan Prov Key Lab Carcinogenesis & Intervent, Haikou, Hainan, Peoples R China
[2] Affiliated Hosp 2, Hainan Med Coll, Dept Med Oncol, Haikou, Hainan, Peoples R China
[3] Inst Tumor, Hainan Med Coll, Haikou, Hainan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
hepatocellular carcinoma; AFP; tumor microenvironment; immune escape; liver cancer stem cells; immunotherapy; CANCER STEM-CELLS; LIVER-CANCER; ANTITUMOR-ACTIVITY; DENDRITIC CELLS; EXPRESSION; AFP; HETEROGENEITY; INITIATION; RESPONSES; PATHWAY;
D O I
10.3389/fonc.2024.1363695
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a prevalent malignant cancer worldwide, characterized by high morbidity and mortality rates. Alpha-fetoprotein (AFP) is a glycoprotein synthesized by the liver and yolk sac during fetal development. However, the serum levels of AFP exhibit a significant correlation with the onset and progression of HCC in adults. Extensive research has demonstrated that the tumor microenvironment (TME) plays a crucial role in the malignant transformation of HCC, and AFP is a key factor in the TME, promoting HCC development. The objective of this review was to analyze the existing knowledge regarding the role of AFP in the TME. Specifically, this review focused on the effect of AFP on various cells in the TME, tumor immune evasion, and clinical application of AFP in the diagnosis and treatment of HCC. These findings offer valuable insights into the clinical treatment of HCC.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
    Wu, Guoyi
    Wu, Jing
    Pan, Xiaoben
    Liu, Bo
    Yao, Zhicheng
    Guo, Yuan
    Shi, Xiaolei
    Ding, Yitao
    [J]. CANCER MEDICINE, 2019, 8 (15): : 6614 - 6623
  • [42] Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy
    Paul, Shashi Bala
    Sahu, Pabitra
    Sreenivas, Vishnubhatla
    Nadda, Neeti
    Gamanagatti, Shivanand R.
    Nayak, Baibaswata
    Shalimar, S.
    Acharya, Subrat K.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) : 1132 - 1137
  • [43] Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
    Gauri Mishra
    Anouk Dev
    Eldho Paul
    Wa Cheung
    Jim Koukounaras
    Ashu Jhamb
    Ben Marginson
    Beng Ghee Lim
    Paul Simkin
    Adina Borsaru
    James Burnes
    Mark Goodwin
    Vivek Ramachandra
    Manfred Spanger
    John Lubel
    Paul Gow
    Siddharth Sood
    Alexander Thompson
    Marno Ryan
    Amanda Nicoll
    Sally Bell
    Ammar Majeed
    William Kemp
    Stuart K. Roberts
    [J]. BMC Cancer, 20
  • [44] Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma
    Hakeem, A. R.
    Young, R. S.
    Marangoni, G.
    Lodge, J. P. A.
    Prasad, K. R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (09) : 987 - 999
  • [45] Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
    Mishra, Gauri
    Dev, Anouk
    Paul, Eldho
    Cheung, Wa
    Koukounaras, Jim
    Jhamb, Ashu
    Marginson, Ben
    Lim, Beng Ghee
    Simkin, Paul
    Borsaru, Adina
    Burnes, James
    Goodwin, Mark
    Ramachandra, Vivek
    Spanger, Manfred
    Lubel, John
    Gow, Paul
    Sood, Siddharth
    Thompson, Alexander
    Ryan, Marno
    Nicoll, Amanda
    Bell, Sally
    Majeed, Ammar
    Kemp, William
    Roberts, Stuart K.
    [J]. BMC CANCER, 2020, 20 (01)
  • [46] The role of alpha-fetoprotein in hepatocellular carcinoma surveillance in a loco-regional Scottish cohort
    Jenks, Sara
    Hey, Shiying
    Gibson, Lorna
    Blunsumi, Andrew
    Sturgeon, Catharine M.
    Hayes, Peter C.
    Bird, Tom G.
    [J]. HEPATOLOGY, 2012, 56 : 450A - 451A
  • [47] Screening for Hepatocellular Carcinoma: The Role of Alpha-fetoprotein and Ultrasound with and without Ultrasound Contrast Agents
    Patel, Nayna
    Lim, Adrian K. P.
    Blomley, Martin J. K.
    Sidhu, Paul
    Taylor-Robinson, Simon D.
    [J]. ULTRASOUND, 2005, 13 (04) : 219 - 225
  • [48] Hepatic Resection for “BCLC Stage A” Hepatocellular Carcinoma. The Prognostic Role of Alpha-Fetoprotein
    Roberto Santambrogio
    Enrico Opocher
    Mara Costa
    Matteo Barabino
    Massimo Zuin
    Emanuela Bertolini
    Francesca De Filippi
    Savino Bruno
    [J]. Annals of Surgical Oncology, 2012, 19 : 426 - 434
  • [49] Serum alpha-fetoprotein levels correlate with dedifferentiation in hepatocellular carcinoma
    Looi, LM
    Cheah, PL
    Goh, KL
    Rosmawati, M
    Vijeyasingam, R
    [J]. 22ND WORLD CONGRESS OF PATHOLOGY & LABORATORY MEDICINE, 2003, : 295 - 297
  • [50] Hepatocellular carcinoma: Patients with increasing alpha-fetoprotein but no mass on ultrasound
    Llovet, JM
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (01) : 29 - 35